These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 17255520)

  • 21. The cultivation of human multipotent mesenchymal stromal cells in clinical grade medium for bone tissue engineering.
    Pytlík R; Stehlík D; Soukup T; Kalbácová M; Rypácek F; Trc T; Mulinková K; Michnová P; Kideryová L; Zivný J; Klener P; Veselá R; Trnený M; Klener P
    Biomaterials; 2009 Jul; 30(20):3415-27. PubMed ID: 19362364
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An effective and safe supplement for stem cells expansion ex vivo: cord blood serum.
    Ma HY; Yao L; Yu YQ; Li L; Ma L; Wei WJ; Lu XM; Du LL; Jin YN
    Cell Transplant; 2012; 21(5):857-69. PubMed ID: 22182982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum.
    Le Blanc K; Samuelsson H; Lönnies L; Sundin M; Ringdén O
    Transplantation; 2007 Oct; 84(8):1055-9. PubMed ID: 17989613
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhanced engraftment of mesenchymal stem cells in a cutaneous wound model by culture in allogenic species-specific serum and administration in fibrin constructs.
    Gregory CA; Reyes E; Whitney MJ; Spees JL
    Stem Cells; 2006 Oct; 24(10):2232-43. PubMed ID: 16763199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.
    In 't Anker PS; Scherjon SA; Kleijburg-van der Keur C; de Groot-Swings GM; Claas FH; Fibbe WE; Kanhai HH
    Stem Cells; 2004; 22(7):1338-45. PubMed ID: 15579651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hematopoiesis capacity, immunomodulatory effect and ex vivo expansion potential of mesenchymal stem cells are not impaired by cryopreservation.
    Zhao ZG; Li WM; Chen ZC; You Y; Zou P
    Cancer Invest; 2008 May; 26(4):391-400. PubMed ID: 18443960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypoxia increases Sca-1/CD44 co-expression in murine mesenchymal stem cells and enhances their adipogenic differentiation potential.
    Valorani MG; Germani A; Otto WR; Harper L; Biddle A; Khoo CP; Lin WR; Hawa MI; Tropel P; Patrizi MP; Pozzilli P; Alison MR
    Cell Tissue Res; 2010 Jul; 341(1):111-20. PubMed ID: 20496083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissimilar differentiation of mesenchymal stem cells from bone marrow, umbilical cord blood, and adipose tissue.
    Rebelatto CK; Aguiar AM; Moretão MP; Senegaglia AC; Hansen P; Barchiki F; Oliveira J; Martins J; Kuligovski C; Mansur F; Christofis A; Amaral VF; Brofman PS; Goldenberg S; Nakao LS; Correa A
    Exp Biol Med (Maywood); 2008 Jul; 233(7):901-13. PubMed ID: 18445775
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IFATS collection: in vivo therapeutic potential of human adipose tissue mesenchymal stem cells after transplantation into mice with liver injury.
    Banas A; Teratani T; Yamamoto Y; Tokuhara M; Takeshita F; Osaki M; Kawamata M; Kato T; Okochi H; Ochiya T
    Stem Cells; 2008 Oct; 26(10):2705-12. PubMed ID: 18535155
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
    Kern S; Eichler H; Stoeve J; Klüter H; Bieback K
    Stem Cells; 2006 May; 24(5):1294-301. PubMed ID: 16410387
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of N-glycolylneuraminic acid xenoantigen on human adipose tissue-derived stromal cells/mesenchymal stem cells leads to safer and more useful cell sources for various stem cell therapies.
    Komoda H; Okura H; Lee CM; Sougawa N; Iwayama T; Hashikawa T; Saga A; Yamamoto-Kakuta A; Ichinose A; Murakami S; Sawa Y; Matsuyama A
    Tissue Eng Part A; 2010 Apr; 16(4):1143-55. PubMed ID: 19863253
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phenotypical and functional characteristics of in vitro expanded bone marrow mesenchymal stem cells from patients with systemic sclerosis.
    Larghero J; Farge D; Braccini A; Lecourt S; Scherberich A; Foïs E; Verrecchia F; Daikeler T; Gluckman E; Tyndall A; Bocelli-Tyndall C
    Ann Rheum Dis; 2008 Apr; 67(4):443-9. PubMed ID: 17526552
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expansion of adipose tissue mesenchymal stromal progenitors in serum-free medium supplemented with virally inactivated allogeneic human platelet lysate.
    Shih DT; Chen JC; Chen WY; Kuo YP; Su CY; Burnouf T
    Transfusion; 2011 Apr; 51(4):770-8. PubMed ID: 21044088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of osteogenic ability of rat mesenchymal stem cells from bone marrow, periosteum, and adipose tissue.
    Hayashi O; Katsube Y; Hirose M; Ohgushi H; Ito H
    Calcif Tissue Int; 2008 Mar; 82(3):238-47. PubMed ID: 18305886
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of alternative mesenchymal stem cell sources for cell banking and musculoskeletal advanced therapies.
    Cavallo C; Cuomo C; Fantini S; Ricci F; Tazzari PL; Lucarelli E; Donati D; Facchini A; Lisignoli G; Fornasari PM; Grigolo B; Moroni L
    J Cell Biochem; 2011 May; 112(5):1418-30. PubMed ID: 21321995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased proliferation of human synovial mesenchymal stem cells with autologous human serum: comparisons with bone marrow mesenchymal stem cells and with fetal bovine serum.
    Nimura A; Muneta T; Koga H; Mochizuki T; Suzuki K; Makino H; Umezawa A; Sekiya I
    Arthritis Rheum; 2008 Feb; 58(2):501-10. PubMed ID: 18240254
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From bone marrow to therapeutic applications: different behaviour and genetic/epigenetic stability during mesenchymal stem cell expansion in autologous and foetal bovine sera?
    Tonti GA; Mannello F
    Int J Dev Biol; 2008; 52(8):1023-32. PubMed ID: 18956335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Isolation and characterization of mouse mesenchymal stem cells.
    Sung JH; Yang HM; Park JB; Choi GS; Joh JW; Kwon CH; Chun JM; Lee SK; Kim SJ
    Transplant Proc; 2008 Oct; 40(8):2649-54. PubMed ID: 18929828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expansion of adipose mesenchymal stromal cells is affected by human platelet lysate and plating density.
    Cholewa D; Stiehl T; Schellenberg A; Bokermann G; Joussen S; Koch C; Walenda T; Pallua N; Marciniak-Czochra A; Suschek CV; Wagner W
    Cell Transplant; 2011; 20(9):1409-22. PubMed ID: 21396157
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical-scale expansion of a mixed population of bone-marrow-derived stem and progenitor cells for potential use in bone-tissue regeneration.
    Dennis JE; Esterly K; Awadallah A; Parrish CR; Poynter GM; Goltry KL
    Stem Cells; 2007 Oct; 25(10):2575-82. PubMed ID: 17585167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.